Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers

PHASE3TerminatedINTERVENTIONAL
Enrollment

613

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

October 28, 2019

Study Completion Date

October 28, 2019

Conditions
Pain
Interventions
DRUG

Ibuprofen 600 mg Immediate Release/Extended Release Caplet

Ibuprofen 600 mg Immediate Release/Extended Release Tablet to be adminstered orally (i.e., one caplet every 12 hours, not to exceed 2 caplets per day) for pain.

Trial Locations (27)

16127

RxXPress Health Mart Pharmacy, Grove City

18015

Family Prescription Center, Bethlehem

21228

Catonsville Pharmacy, Catonsville

23192

Montpelier Pharmacy, Inc., Montpelier

30540

Huff's Drug Store, Ellijay

33133

Coconut Grove Pharmacy, Miami

33578

Summerfield Pharmacy, Riverview

35226

Mills Pharmacy at Bluff Park, Hoover

37087

Buckeye Drugs, Lebanon

37311

Medical Center Compounding Pharmacy & Health Center, Cleveland

42320

Rice's Pharmacy, Beaver Dam

55068

Cub Pharmacy #744, Rosemount

55303

Goodrich Pharmacy, Anoka

55330

Kemper Corner Drug, Elk River

58501

Dakota Pharmacy of Bismarck, Bismarck

62249

Family Care Pharmacy, Highland

63343

The Medicine Shoppe and Elsberry Pharmacy, Elsberry

64111

Albers Medical Pharmacy, Kansas City

64485

Countryside Pharmacy, Savannah

75092

The Medicine Shoppe #708, Sherman

75701

BrickStreet Pharmacy, Tyler

77044

Summerwood Pharmacy and Compounding, Houston

84010

Bountiful Drug, Bountiful

84121

The Medicine Center, Salt Lake City

85202

Community Clinical Pharmacy, Mesa

85704

ACACIA Apothecary and Wellness, Tucson

08831

Texas Road Pharmacy, Monroe

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03722238 - Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers | Biotech Hunter | Biotech Hunter